Xunlei Zhang
Overview
Explore the profile of Xunlei Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji J, Zhang X, Yuan S, Liu H, Yang L
Asian J Surg
. 2024 Feb;
47(4):1769-1775.
PMID: 38302357
Background: A comprehensive understanding of gastric signet ring cell carcinoma (SRCC) is limited. The aim of our study was to analyze metastatic patterns of gastric SRCC and evaluate impacts of...
2.
Zhang X, Qiu X, Yin H, Zhao W, Song L, Zhang X, et al.
Biomarkers
. 2023 Dec;
28(8):714-721.
PMID: 38059615
Objective: There are many factors that affect the survival of patients with gastric cancer, such as TNM stage, the patient's nutritional status, inflammation, and so on. In this study, the...
3.
Qi X, Chen J, Wei S, Ni J, Song L, Jin C, et al.
BMJ Open
. 2023 Nov;
13(11):e074874.
PMID: 37996220
Objective: Platelet-to-lymphocyte ratio (PLR), known as a key systemic inflammatory parameter, has been proved to be associated with response to neoadjuvant therapy in breast cancer (BC); however, the results remain...
4.
Zhang X, Qiu X, Zhao W, Song L, Zhang X, Yang L, et al.
Cancer Control
. 2023 Apr;
30:10732748231169403.
PMID: 37071790
Background: ARID3B (AT-rich interaction domain 3B) has been demonstrated to be associated with the progression and patient prognosis of several human tumors. We conducted the present study to investigate the...
5.
Qiu X, Shen C, Zhao W, Zhang X, Zhao D, Wu X, et al.
Sci Rep
. 2022 Sep;
12(1):15419.
PMID: 36104345
Although there have been studies correlating DYRK2 with a number of human cancers, there has been no pan-cancer analysis. Therefore, through the TCGA database, we conducted a related study on...
6.
Wang Y, Li T, Yang L, Zhang X, Wang X, Su X, et al.
Cell Cycle
. 2022 Aug;
21(24):2590-2601.
PMID: 36005478
Accumulating evidence has unfolded the significance of extracellular vesicles (EVs) in diseases and cancers. Here, we attempted to discuss the role of cancer-associated fibroblasts (CAFs)-derived EVs containing miR-199a-5p in gastric...
7.
Chen J, Wei S, Zhao T, Zhang X, Wang Y, Zhang X
Dis Markers
. 2022 Aug;
2022:7137357.
PMID: 35945957
Background: To assess the prognostic value of pretreatment serum biomarkers in stage IV non-small-cell lung cancer (NSCLC) patients treated with PD-1 (programmed cell death protein 1) inhibitors and their value...
8.
Qiu X, Shen C, Zhao W, Zhang X, Zhao D, Zhu Y, et al.
J Cancer
. 2022 May;
13(7):2246-2257.
PMID: 35517424
In order to investigate the prognostic value of a novel biomarker combining serum carcinoembryonic antigen (CEA) and hemoglobin (HB) levels in patients with resectable gastric cancer. This retrospective study assessed...
9.
Chen J, Shao J, Zhang X, Wei S, Cai H, Wang G
Ann Transl Med
. 2022 Apr;
10(5):253.
PMID: 35402598
Background: This study aimed to determine whether plasma cell-free DNA (cfDNA) and pretreatment parameters provide useful therapeutic response and prognostic information for advanced non-small cell lung cancer (NSCLC) patients. Methods:...
10.
Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, et al.
Front Oncol
. 2022 Feb;
11:793678.
PMID: 35111675
Gastric cancer is a deadly human malignancy and the molecular mechanisms underlying gastric cancer pathophysiology are very complicated. Thus, further investigations are warranted to decipher the underlying molecular mechanisms. With...